Navigation Links
Huifeng Bio-Pharmaceutical Provides Preliminary 2009 Financial Results and 2010 Guidance
Date:2/4/2010

XI'AN, China, Feb. 4 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced preliminary 2009 results and provided guidance for 2010.

Huifeng Bio-Pharmaceutical Technology anticipates revenues between $13 million to $14 million for the full year ended December 31, 2009. This represents a year-over-year revenue growth of 27% to 35%. Preliminary 2009 net income is anticipated to be between $2.8 million to $3.0 million for the year, representing 80% to 93% year-over-year growth. "The increase was attributed to the increase in the company's sales of pharmaceutical raw-material and Plant Extractive, and other products, including Rutin, Quercetin, injectable Troxerutin and Diosmin," said the company's CEO Jing'An Wang. "The increase in revenue reflected both a gain in new customers, as well as an increase in the number of orders from our existing customers."

2010 Guidance

Management is providing revenue guidance of $20 million to $25 million and net income guidance between $4.5 million to $5.0 million for 2010. Growth is expected to be driven by increasing sales of current products. Because of the EU COS for Diosmin, the company has a high level diosmin quality. Certain European customers will be interested in Huifeng's diosmin and will increase their purchasing quantity from the company. The company will begin to perform the contract with Safic-Alan for diosmin. Another driver is production line expansion and acquisition which will increase the production quantity of dio
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
2. Huifeng Bio-Pharmaceutical (HFGB) Reports Record Sales and Net Income
3. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
4. Study provides hope that some transplant patients could live free of antirejection drugs
5. Study provides hope that some transplant patients could live free of anti-rejection drugs
6. USAID Provides Additional Wildfire Assistance to Greece
7. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
8. New knock-out gene model provides molecular clues to breast cancer
9. PreMD Provides Update on 510(k) Application for PREVU(x) POC
10. SIV infection of natural hosts provides new insights into HIV disease complexity
11. Microarray provides 3 genomic guides to breast cancer treatment decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... HealthDay Reporter , MONDAY, July 28, 2014 ... disease may be able to take hormone replacement therapy soon ... according to a new study. Previous studies, including the ... harmful effects on the heart. But, many of those women ... further past menopause. In this new study, researchers ...
(Date:7/29/2014)... Beverly Hills, CA (PRWEB) July 29, 2014 ... the world’s largest uterine fibroid was recently removed from a ... 3 hours. The woman, identified only as Latha, reportedly had ... inside her. She had been experiencing fatigue and breathlessness for ... The doctors at Kumaran Hospital in Chennai only discovered the ...
(Date:7/29/2014)... AR (PRWEB) July 29, 2014 On ... a resolution declaring the week of October 12-18, 2014, ... of case management in improving healthcare outcomes for patients. ... and Senator John Boozman (R-AR), with support by the ... Management Association to honor case management professionals for their ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The ... named a 2014 ASAE Power of A ... public awareness campaign to encourage everyone age six months ... , ASAE recognized NFID for its power to enrich ... and action among consumers and professionals about the importance ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Award-winning inventor Michael ... a flatulence neutralizer specifically designed to absorb embarrassing odors in ... that can easily be stored in a desk drawer. This ... the PoofPad, users will simply sit on the pad and ... at the office and then BAM, someone appears out of ...
Breaking Medicine News(10 mins):Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3
... issue of the Journal of Clinical Sleep Medicine ... developing obstructive sleep apnea (OSA) in adolescents but not in ... of OSA among Caucasian adolescents 12 years of age and ... mass index (BMI) z-score, while the risk of OSA did ...
... Medical Center researchers have provided the most extensive account ... patients with an extremely rare premature aging syndrome. ... of the Journal of Clinical Endocrinology and Metabolism, ... should not be lumped together with those diagnosed with ...
... , , OAK BROOK, Ill., Dec. 15 ... larger role than ever. Now the University HealthSystem Consortium (UHC) ... Achieving Cost Efficiencies in Health Care, to assist value ... with the input of value analysis staff in the field, ...
... ... help people slim down, reduce facial wrinkling, and plump lips all in one minimally ... ... fat from the abdomen and inject it into the face and lips to help ...
... , ABBOTT PARK, Ill. and HOLLYWOOD, ... ) announced today a definitive agreement to acquire STARLIMS ... of laboratory information management systems, for approximately $123 million ... position in the global diagnostics market, providing advanced web-based ...
... LOVELAND, Colo., Dec. 14 Heska Corporation (Nasdaq: ... leading provider of veterinary diagnostic and specialty products, ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... Customers receiving these analyzers have invested in the ...
Cached Medicine News:Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... RIDGE, Colo. , July 29, 2014 /PRNewswire/ ... company focused on developing a proprietary electromagnetic induction ... it entered into an agreement under which TBC ... Continuation Investments Limited (COT) in an all-stock transaction. ... Company will initially trade on the Australian Stock ...
(Date:7/29/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or ... in China , today announced that ... results on Tuesday, August 5, 2014 after the market ... a conference call at 8:00 a.m. ET on Wednesday, ... on August 6, 2014, to discuss second quarter 2014 ...
Breaking Medicine Technology:A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3
... March 29, 2011 Royal DSM, the global ... the Ambassador of the Kingdom of the Netherlands to ... North Carolina facilities on March 28, 2011. Ambassador Jones-Bos ... and Dyneema-Ultra-High Molecular Weight Polyethylene fiber operations, and toured ...
... 2011 Diopsys, Inc. has launched the new Diopsys® ... ophthalmologists detect optic nerve disease, including glaucoma and other ... leading cause of blindness in the world, reports the ... is often called the "sneak thief of sight" because ...
Cached Medicine Technology:Dutch Ambassador Visits DSM in North Carolina 2Dutch Ambassador Visits DSM in North Carolina 3New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma 2
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
Medicine Products: